Paul Lammers, MD

Company: Triumvira Immunologics

Job title: CEO

Seminars:

Natural Activation of T-Cells Through the TAC Receptor Provides Ideal Characteristics for Adoptive Cell Therapy 11:30 am

Unique structure and biology of TAC T-cells Deep penetration and activation of TAC T-cells into solid tumors Update on TAC01-HER2 Phase I/II clinical trial in patients with HER2-overexpressing solid tumorsRead more

day: Conference Day Two